Douglas W. Grosenbach
Siga Technologies (United States)(US)
Publications by Year
Research Areas
Poxvirus research and outbreaks, Herpesvirus Infections and Treatments, Immunotherapy and Immune Responses, Bacillus and Francisella bacterial research, T-cell and B-cell Immunology
Most-Cited Works
- → Oral Tecovirimat for the Treatment of Smallpox(2018)409 cited
- → Phase I Study of Sequential Vaccinations With Fowlpox-CEA(6D)-TRICOM Alone and Sequentially With Vaccinia-CEA(6D)-TRICOM, With and Without Granulocyte-Macrophage Colony-Stimulating Factor, in Patients With Carcinoembryonic Antigen–Expressing Carcinomas(2004)296 cited
- → A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.(2006)291 cited
- → An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications(2020)203 cited
- → IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity(2007)185 cited
- → A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein(2012)163 cited
- Synergy of vaccine strategies to amplify antigen-specific immune responses and antitumor effects.(2001)
- → Clinical Safety of a Viral Vector Based Prostate Cancer Vaccine Strategy(2007)124 cited
- → Chlamydia psittaci IncA is phosphorylated by the host cell and is exposed on the cytoplasmic face of the developing inclusion(1997)115 cited
- → Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase(2013)110 cited